Inventor · disambiguated record
Joël Vacus
Also filed as: VACUS JOEL · VACUS JOëL
5 granted patents·3 pending applications·83 citations·filing 1997–2024
76Inventor score
Files withENYO PHARMA3RHONE POULENC RORER SA2AVENTIS PHARMA SA1COMMISSARIAT ENERGIE ATOMIQUE1INST RECH DEVELOPPEMENT IRD1
Top patents by PatentIndex Score
8 records- 0185US12030861B1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2023·Granted Jul 9, 2024·2 cites·48 claims
- 0279US6146663AStabilized nanoparticles which may be filtered under sterile conditionsRHONE POULENC RORER SA·Filed 1997·Granted Nov 14, 2000·76 cites·20 claims
- 0366US2025019358A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 0456US2025019370A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 0544US8344145B2Salts of 2-substituted quinolinesINST RECH DEVELOPPEMENT IRD·Filed 2009·Granted Jan 1, 2013·0 cites·6 claims
- 0644US2020281873A1Adamantane or Bicyclic Monoterpenoid Derivatives for Use in the Treatment of LeishmaniasisCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2018·Application pending·0 cites
- 0734US6187746B1Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereofRHONE POULENC RORER SA·Filed 1998·Granted Feb 13, 2001·3 cites·46 claims
- 0824US6156338AMethod for preparing compositions for transferring nucleic acidsAVENTIS PHARMA SA·Filed 1997·Granted Dec 5, 2000·2 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Joël Vacus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →